Four year prospective evaluation of nosocomial bacteremia: Epidemiology, microbiology, and patient outcome

Diagnostic Microbiology and Infectious Disease

Volumn 38, Issue 3, 2000, Pages 131-140

  Lark, Rebecca L ^a   Chenoweth, Carol ^a,e   Saint, Sanjay ^a,b   Zemencuk, Judith K ^b   Lipsky, Benjamin A ^c,d   Plorde, James J ^c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; METICILLIN; OXACILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOOD CULTURE; BODY TEMPERATURE; CANDIDIASIS; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMORBIDITY; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; FUNGEMIA; HEMODYNAMICS; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SHOCK; STAPHYLOCOCCUS AUREUS;

ADULT; BACTEREMIA; BACTERIA; CANDIDA; CANDIDIASIS; CROSS INFECTION; FEMALE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; WASHINGTON;

EID: 0033671121     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00192-9     Document Type: Article

References (26)

1. The epidemiology of hematogenous candidiasis caused by different Candida species
2. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System
3. Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997
4. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit
5. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
6. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
7. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome
8. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999
9. Prevention of intravascular catheter-related infections
10. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
11. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee
12. Nosocomial bloodstream infections
13. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality
14. Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model
15. Nosocomial bloodstream infection in critically ill patients
16. Nosocomial bloodstream infections
17. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group
18. Impact of nosocomial infections on outcome: Myths and evidence
19. A three-year study of positive blood cultures, with emphasis on prognosis
20. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis
21. A decade of prevalence surveys in a tertiary-care center: Trends in nosocomial infection rates, device utilization, and patient activity
22. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis
23. Clinical importance of polymicrobial bacteremia
24. The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations
25. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
26. Hospital-acquired candidemia: The attributable mortality and excess length of stay